Tuberculosis in India. Go to Publication You Might Also Like Prognostic Factors for Adverse Outcomes in COVID-19 Infection September 3, 2020 The epidemiology, pathogenesis, transmission, diagnosis, and management of multidrug-resistant, extensively drug-resistant, and incurable tuberculosis. March 15, 2017 Nomenclature of drug-resistant tuberculosis. November 11, 2013 Resistance to second-line drugs in multidrug-resistant tuberculosis. February 23, 2013 Multidrug-resistant-tuberculosis treatment in the Indian private sector: Results from a tertiary referral private hospital in Mumbai. October 30, 2014
The epidemiology, pathogenesis, transmission, diagnosis, and management of multidrug-resistant, extensively drug-resistant, and incurable tuberculosis. March 15, 2017
Multidrug-resistant-tuberculosis treatment in the Indian private sector: Results from a tertiary referral private hospital in Mumbai. October 30, 2014